AbbVie Inc. Annual Operating Income (Loss) in USD from 2011 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
AbbVie Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- AbbVie Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.49B, a 147% decline year-over-year.
- AbbVie Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $9.14B, a 28.4% decline year-over-year.
- AbbVie Inc. annual Operating Income (Loss) for 2024 was $9.14B, a 28.4% decline from 2023.
- AbbVie Inc. annual Operating Income (Loss) for 2023 was $12.8B, a 29.6% decline from 2022.
- AbbVie Inc. annual Operating Income (Loss) for 2022 was $18.1B, a 1.08% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)